In addition, glioma with retained nuclear H3K27me3, loss of ATRX staining, and IDH1-R132H positivity can be predicted as 1p/19q non-codeleted glioma with a probability score of 0.9823. This evidence concerns the gene IDH1 and central nervous system cancer.